logo
 
The Hyderabad-based Centre for Cellular and Molecular Biology (CCMB) has announced the development of country’s first potential mRNA vaccine candidate to fight SARS-CoV-2.

CCMB Director Dr Vinay Kumar N. informed that the indigenously developed mRNA vaccine candidate is undergoing pre-clinical studies to evaluate its efficacy to protect against live virus infection.

He said the mRNA vaccine candidate and the technology, developed by a team of researchers from the Atal Incubation Centre-CCMB (AIC-CCMB), is fully indigenous and devoid of any technology contributions from elsewhere.

He further said they observed robust immune response against SARS-CoV-2 Spike protein in mice, upon administration of two doses of the mRNA. The anti-Spike antibodies generated were found to be more than 90 percent efficient in preventing the human ACE2 receptor binding to the coronavirus.  

CEO, AIC-CCMB, Dr Madhusudhana Rao said the research team were able to establish mRNA vaccine technology and develop a home-grown mRNA vaccine candidate against SARS-CoV-2 in less than a year since the inception of the project.



No Comments For This Post, Be first to write a Comment.
Leave a Comment
Name:
Email:
Comment:
Enter the code shown:


Can't read the image? click here to refresh

Todays Epaper

neerus indian ethnic wear
Latest Urdu News

Which cricket team will win the IPL 2022?

Gujarat Titans
Lucknow Super Giants
Rajasthan Royals